title: Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells.
abstract: Withaferin A (WA), a bioactive constituent of Ayurvedic medicine plant Withania somnifera, is a potent apoptosis inducer in cancer cells but the mechanism of cell death induction is not fully characterized. The present study was undertaken to determine the role of mitogen-activated protein kinases (MAPK), including c-jun NH2 -terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 MAPK, and anti-apoptotic protein myeloid cell leukemia-1 (Mcl-1) in regulation of WA-induced apoptosis using human breast cancer cells. Exposure of MCF-7 (estrogen responsive) and SUM159 (triple negative) human breast cancer cells to WA resulted in increased phosphorylation of ERK, JNK, and p38 MAPK, but these effects were relatively more pronounced in the former cell line than in SUM159. Overexpression of manganese-superoxide dismutase conferred partial protection against WA-mediated hyperphosphorylation of ERK, but not JNK or p38 MAPK. Cell death resulting from WA treatment in MCF-7 cells was significantly augmented by pharmacological inhibition of ERK and p38 MAPK. Interestingly, the WA-induced apoptosis in MCF-7 cells was partially but significantly blocked in the presence of a JNK-specific inhibitor. Pharmacological inhibition of ERK or JNK had no effect on WA-induced apoptosis in SUM159 cells. The WA-treated cells exhibited induction of long and short forms of Mcl-1. RNA interference of Mcl-1 alone triggered apoptosis. Furthermore, the WA-induced cell death in MCF-7 cells was modestly but significantly augmented by knockdown of the Mcl-1 protein. These observations indicate that: MAPK have cell line-specific role in cell death by WA, and Mcl-1 induction confers modest protection against WA-induced apoptosis.
authors.affiliation: Department of Pharmacology and Chemical Biology, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
authors.forename: Eun-Ryeong
authors.initials: ER
authors.lastname: Hahm
authors.forename: Joomin
authors.initials: J
authors.lastname: Lee
authors.forename: Shivendra V
authors.initials: SV
authors.lastname: Singh
mesh_terms: D000873:Anthracenes / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects* / Q000235:genetics; D045744:Cell Line, Tumor; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D005260:Female; D005419:Flavonoids / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D048031:JNK Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D061986:MCF-7 Cells; D064549:Myeloid Cell Leukemia Sequence 1 Protein / Q000235:genetics*; D010766:Phosphorylation; D011725:Pyridines / Q000494:pharmacology; D034622:RNA Interference; D034741:RNA, Small Interfering; D013482:Superoxide Dismutase / Q000096:biosynthesis; D064726:Triple Negative Breast Neoplasms / Q000188:drug therapy*; D054358:Withanolides / Q000494:pharmacology*; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D000873:Anthracenes; D000970:Antineoplastic Agents; D005419:Flavonoids; D007093:Imidazoles; C579095:MCL1 protein, human; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D011725:Pyridines; D034741:RNA, Small Interfering; D054358:Withanolides; C432165:pyrazolanthrone; D013482:Superoxide Dismutase; D048049:Extracellular Signal-Regulated MAP Kinases; D048031:JNK Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; C009684:withaferin A; C090942:4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
keywords: MAPK; Mcl-1; apoptosis; breast cancer; withaferin A
references.citation: Apoptosis. 2008 Dec;13(12):1450-64
references.pmid: 18987975
references.citation: Carcinogenesis. 2011 Nov;32(11):1697-705
references.pmid: 21859835
references.citation: Mol Cancer Ther. 2010 Jan;9(1):202-10
references.pmid: 20053782
references.citation: Apoptosis. 2011 Oct;16(10):1014-27
references.pmid: 21710254
references.citation: J Nat Prod. 2010 Sep 24;73(9):1476-81
references.pmid: 20726569
references.citation: Cancer Res. 2008 Sep 15;68(18):7661-9
references.pmid: 18794155
references.citation: Cell Mol Life Sci. 2009 Apr;66(8):1326-36
references.pmid: 19099185
references.citation: Hum Exp Toxicol. 2005 Mar;24(3):137-47
references.pmid: 15901053
references.citation: Mol Carcinog. 2011 Aug;50(8):614-24
references.pmid: 21432907
references.citation: Mol Pharmacol. 2007 Feb;71(2):426-37
references.pmid: 17093135
references.citation: J Biol Chem. 2000 Jul 21;275(29):22136-46
references.pmid: 10766760
references.citation: J Biol Chem. 2007 Feb 16;282(7):4253-4264
references.pmid: 17150968
references.citation: Carcinogenesis. 2003 May;24(5):891-7
references.pmid: 12771033
references.citation: Clin Cancer Res. 2007 Apr 1;13(7):2298-306
references.pmid: 17404115
references.citation: J Biol Chem. 2008 Oct 31;283(44):30151-63
references.pmid: 18768478
references.citation: Biochem Pharmacol. 2012 Nov 15;84(10):1241-50
references.pmid: 22981381
references.citation: Mol Nutr Food Res. 2013 May;57(5):840-53
references.pmid: 23322423
references.citation: Breast Cancer Res Treat. 2012 Nov;136(1):45-56
references.pmid: 22965833
references.citation: Indian J Exp Biol. 1993 Jul;31(7):607-11
references.pmid: 8225418
references.citation: Carcinogenesis. 2010 Nov;31(11):1991-8
references.pmid: 20724373
references.citation: Oncogene. 2004 Jul 22;23(33):5594-606
references.pmid: 15184882
references.citation: Indian J Exp Biol. 2009 Jan;47(1):16-23
references.pmid: 19317347
references.citation: Int J Cancer. 2011 Dec 1;129(11):2744-55
references.pmid: 21538350
references.citation: PLoS One. 2010 Apr 16;5(4):e10105
references.pmid: 20419128
references.citation: Expert Opin Investig Drugs. 2011 Oct;20(10):1397-411
references.pmid: 21851287
references.citation: Int J Cancer. 1971 Nov 15;8(3):487-96
references.pmid: 5002873
references.citation: Nutr Cancer. 2008;60 Suppl 1:51-60
references.pmid: 19003581
references.citation: Biochem Pharmacol. 2012 Nov 15;84(10):1282-91
references.pmid: 22981382
references.citation: Cancer Res. 2007 Jan 1;67(1):246-53
references.pmid: 17185378
references.citation: PLoS One. 2011;6(8):e23354
references.pmid: 21853114
references.citation: J Cell Biochem. 2012 Feb;113(2):599-610
references.pmid: 21956685
references.citation: J Soc Integr Oncol. 2007 Winter;5(1):25-37
references.pmid: 17309811
references.citation: Apoptosis. 2008 Dec;13(12):1494-504
references.pmid: 19002588
references.citation: Mol Cell Biochem. 2004 May;260(1-2):39-47
references.pmid: 15228084
references.citation: Curr Cancer Drug Targets. 2013 Jul;13(6):640-50
references.pmid: 23607597